Finasteride for recurrent priapism in children and adolescents: a report on 5 cases

• Main Authors: Ubirajara Barroso Jr., Thamy C.S. Marques, Hugo F.F. Novaes
• Format: Article
• Language: English
• Published: Sociedade Brasileira de Urologia 2012-10-01
• Series: International Brazilian Journal of Urology
• Subjects: Priapism; Child; Anemia, Sickle Cell; Finasteride
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382012000500014

PURPOSE: Recurrent priapism is prevalent in children. Different medications have been used to avoid new episodes, however, there is no consensus regarding the best option. The use of finasteride to treat priapism in adults has already been tested. The aim of the present study was to test the hypothesis that a low dose of finasteride would be effective in preventing recurrent priapism in children. MATERIALS AND METHODS: Since 2007, five children and adolescents with recurrent episodes of priapism have been treated with finasteride in our department, and the medical records of these patients were reviewed for this study. In four cases, the dose used was 1 mg a day, while the remaining patient used 1 mg twice a day. RESULTS: Prior to initiating finasteride treatment, one patient reported having had 6 episodes of acute priapism, while the remaining patients had more than 10 episodes. One of the patients reported having stuttering priapism almost daily. With a mean follow-up of 20 months, four patients had no episodes and only one patient complained of sporadic and shorter duration episodes. CONCLUSIONS: These initial results suggest that a low daily dose of finasteride appears to represent an effective and safe form of treatment for recurrent priapism in children and adolescents with SCD. However, in order to confirm these initial findings, studies with a large population and a control group are essential.